1. "2022"
Formats
  1. Journal Article (2449)
  2. Meeting Abstract (2196)
  3. Review (615)
  4. Editorial (363)
  5. Book Section (139)
  6. Correspondence (117)
  7. Guidelines (112)
  8. Research Letter (82)
  9. Miscellaneous (60)
  10. Conference Paper (29)
  11. Book Whole (6)
Groups
  1. Department of Medicine (2621)
  2. Solid Tumor Oncology Division (1573)
  3. Sloan Kettering Institute Postdocs (1364)
  4. GSK Faculty (1152)
  5. Surgery (1036)
  6. Hematologic Malignancies, Division of (964)

More Groups

People
  1. Miguel-Angel Perales (95)
  2. Alexander Drilon (85)
  3. Saad Usmani (83)
  4. Sergio Giralt (77)
  5. Marc Ladanyi (72)
  6. Gilles Salles (69)

More People

Years
  1. 2022 (6168)
Publications
  1. Journal of Clinical Oncology (520)
  2. Blood (319)
  3. Cancer Research (191)
  4. Annals of Oncology (158)
  5. Annals of Surgical Oncology (134)
  6. International Journal of Radiation Oncology, Biology, Physics (132)

More Publications

Publishers
  1. Elsevier Inc. (794)
  2. American Society of Clinical Oncology (583)
  3. Springer (440)
  4. Nature Publishing Group (379)
  5. American Society of Hematology (369)
  6. Oxford University Press (360)

More Publishers

Results (6168)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Understanding individual differences in patient-reported outcomes using novel bayesian varying intercepts modeling - An example in neurocognitive impairments in cancer survivors
    Meeting Abstract

    Li, Y.; Schofield, E.; Root, J.; Ryan, E.; Gaynor, A.; Ahles, T.
    Quality of Life Research (2022)

    Fulltext@MSK | Save
  • EV-301 long-term outcomes: 24-month findings from phase 3 trial of enfortumab vedotin vs chemotherapy in previously treated advanced urothelial carcinoma
    Meeting Abstract

    Rosenberg, J.; Powles, T.; Sonpavde, G.; Loriot, Y.; Duran, I.; Lee, J.; Matsubara, N.; Vulsteke, C.; Castellano, D.; Mamtani, R.; more...
    Swiss Medical Weekly (2022)

    Fulltext@MSK | Save
  • AXL tyrosine kinase mediates escape from type II JAK2 inhibition in myeloproliferative neoplasms
    Meeting Abstract

    Codilupi, T.; Szybinski, J.; Brkic, S.; Stivala, S.; Yang, J. L.; Ghosh, N.; Passweg, J. R.; Angelillo-Scherrer, A.; Dirnhofer, S.; Levine, R. L.; more...
    Swiss Medical Weekly (2022)

    Fulltext@MSK | Save
  • Single cell genotyping of matched stem/progenitor and mature blood cells in treatment naive and AZA-treated MDS and CMML reveals significant contribution of mutated clones to blood production
    Meeting Abstract

    Schnegg-Kaufmann, A.; Thoms, J. A.; Bhuyan, G. S.; Hampton, H. R.; Vaughan, L.; Rutherford, K.; Kakadia, P. M.; Lee, H. M.; Johansson, E. M.; Failes, T.; more...
    Swiss Medical Weekly (2022)

    Fulltext@MSK | Save
  • Reliability and validity of PRO-CTCAE daily reporting with a 24-hour recall period
    Meeting Abstract

    Lee, M.; Basch, E.; Langlais, B.; Thanarajasingam, G.; Ginos, B.; Rogak, L.; Mendoza, T.; Bennett, A.; Schrag, D.; Mazza, G.; more...
    Quality of Life Research (2022)

    Fulltext@MSK | Save
  • A phase I trial of targeted immunotherapy with daratumumab following myeloablative total body irradiation (TBI)-based conditioning and allogeneic hematopoietic cell transplantaton in children, adolescents and young adults with high-risk T-cell acute lymphoblastic leukemia and lymphoma (T- ALL/T-LLy) (ALLO-T-DART) (IND 159396): A PTCTC facilitated study
    Meeting Abstract

    Quigg, T.; Flower, A.; Teachey, D.; Lim, M.; Chu, Y.; Harrison, L.; Morris, E.; Gardenswartz, A.; Hochberg, J.; Ozkaynak, M.; more...
    Leukemia Research (2022)

    Fulltext@MSK | Save
  • TASPase1 orchestrates fetal liver hematopoietic stem cell fate by cleaving a basal transcription factor TFIIA
    Meeting Abstract

    Niizuma, H.; Cheng, E.; Hsieh, J.
    Pediatric Blood and Cancer (2022)

    Fulltext@MSK | Save
  • Burkitt lymphoma and high-grade B-cell lymphphoma with 11q abberrations share a transcriptional profile resembling a subpopulation of early dark zone cells
    Meeting Abstract

    Di Stefano, G.; Chteinberg, E.; Loeffler-Wirth, H.; Hillebrecht, S.; Wagener, R.; Abramov, D.; Burkhardt, B.; Louissant, A.; Horn, H.; Mottok, A.; more...
    Leukemia Research (2022)

    Fulltext@MSK | Save
  • Evidence-based definition of region of interest (ROI) for abdominal DIBH surface-guided radiotherapy
    Meeting Abstract

    Song, Y.; Zhai, X.; Liang, Y.; Zeng, C.; Mueller, B. A.; Li, G.
    International Journal of Radiation Oncology, Biology, Physics (2022)

    Fulltext@MSK | Save
  • Value-based cancer care: How are we training future radiation oncologists on the quality/cost equation?
    Meeting Abstract

    Bell, L.; Chino, F.
    International Journal of Radiation Oncology, Biology, Physics (2022)

    Fulltext@MSK | Save